Impact of medicare part D on utilization and expenditures

American Journal of Pharmacy Benefits

Volumn 2, Issue 3, 2010, Pages 209-220

  Nair, Kavita V ^a   Jan, Saira A ^b   Wolfe, Pamela ^c   Allen, Richard Read ^d   Saseen, Joseph J ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY   (United States)

^c Global Health and Health Disparities   (United States)

^d Peakstat Statistical Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG COST; DRUG USE; DYSLIPIDEMIA; FEMALE; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICARE; PATIENT ATTITUDE; PURCHASING;

EID: 77954716015     PISSN: 19454481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Henry J. Kaiser Family Foundation. Medicare health and prescription drug plan tracker. http://healthplantracker.kff.org/. Accessed November 15, 2006.
2. Dubow J. Payment to Medicare+Choice organizations. AARP Public Policy Institute research report. April 2000. http://www.aarp.org/research/ppi/health-care/medicare/articles/aresearch-import-649-DD47.html. Accessed June 25, 2009.
3. Achman L, Harris L. Early effects of the Medicare Modernization Act: benefits, cost sharing, and premiums of Medicare Advantage Plans, 2005. AARP Public Policy Institute Web site. April 2005. http://www.aarp.org/research/ppi/health-care/medicare/articles/2005_02_mma.html. Accessed June 24, 2009.
4. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22): 2349-2359.
5. Tseng CW, Brook E, Keeler E, Steers WN, Mangione CM. Cost lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in coverage. JAMA. 2004;292(8): 952-960.
6. Rector TS, Venus PJ. Do drug benefits help Medicare beneficiaries afford prescribed drugs? Health Aff (Millwood). 2004;23(4):213-223.
7. Joyce GF, Goldman DP, Karaca-Mandic P, Zheng Y. Pharmacy benefit caps and the chronically ill. Health Aff (Millwood). 2007;26(5):1333-1343.
8. Hoadley J, Thompson J, Hargrave E, Cubanski J, Neuman T. Medicare Part D 2009 data spotlight. Henry J. Kaiser Family Foundation Web site. http://www.kff.org/medicare/7834.cfm. Accessed February 15, 2009.
9. Lichtenberg FR, Sun XS. The impact of Medicare Part D on prescription use by the elderly. Health Aff (Millwood). 2007;26(6): 1735-1744.
10. Yin W, Basu A, Zhang JX, Rabbani A, Meltzer DO, Alexander GC. The effect of Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med. 2008;148(3):169-177.
11. Ketcham JD, Simon KI. Medicare Part D's effects on elderly patients' drug costs and utilization. Am J Manag Care. 2008;14:(11 suppl):SP14-SP22.
12. Karaca Z, Streeter SB, Barton V, Nguyen K, Norris K; For Avalere Health. The impact of Medicare Part D on beneficiaries with type 2 diabetes. March 2008. http://www.avalerehealth.net/wm/show.php?c=1&id=772. Accessed June 24, 2009.
13. Schneeweiss S, Maclure M, Soumerai SB, Walker AM, Glynn RJ. Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance. J Clin Epidemiol. 2002;55(8):833-841.
14. Healthcare Cost and Utilization Project. Chronic condition indicator. http://www.hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jsp. Accessed January 14, 2009.
15. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for the evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565-574.
16. Robst J, Levy JM, Ingber MJ. Diagnosis based risk adjustment for Medicare prescription drug plan payments. Health Care Financ Rev. 2007;28(4):15-30.
17. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
18. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman and Hall; 1993.
19. Hardin JW, Hilbe JM. Generalized Linear Models and Extensions. 2nd ed. College Station, TX: StataCorp LP; 2007.
20. Schneider KM, O'Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States. Health Qual Life Outcomes. 2009;7:82.